Table 8.
The top 20 high-cited FMT-related systematic reviews and meta-analyses.
| No. | Applications | DOI | First author | Year | Journals | IF | JCR | TC |
|---|---|---|---|---|---|---|---|---|
| 1 | Clostridium difficile infection | 10.1038/ajg.2013.59 | Kassam | 2013 | The American Journal of Gastroenterology | 12.045 | Q1 | 579 |
| 2 | Inflammatory bowel disease | 10.1016/j.crohns.2014.08.006 | Colman | 2014 | Journal of Crohn's and Colitis | 10.020 | Q1 | 283 |
| 3 | Recurrent and refractory CDI | 10.1111/apt.14201 | Quraishi | 2017 | Alimentary Pharmacology & Therapeutics | 9.524 | Q1 | 282 |
| 4 | Inflammatory bowel disease | 10.1093/ecco-jcc/jjx063 | Paramsothy | 2017 | Journal of Crohn's and Colitis | 10.020 | Q1 | 225 |
| 5 | Active ulcerative colitis | 10.1111/apt.14173 | Costello | 2017 | Alimentary Pharmacology & Therapeutics | 9.524 | Q1 | 150 |
| 6 | Active ulcerative colitis | 10.1097/MIB.0000000000001228 | Narula | 2017 | Inflammatory Bowel Disease | 7.290 | Q1 | 111 |
| 7 | Clostridium difficile infection | 10.1111/apt.13492 | Li | 2016 | Alimentary Pharmacology & Therapeutics | 9.524 | Q1 | 97 |
| 8 | Clostridium difficile infection | 10.1177/2050640618780762 | Ianiro | 2018 | United European Gastroenterology Journal | 6.866 | Q1 | 92 |
| 9 | Irritable bowel syndrome | 10.1111/apt.15330 | Ianiro | 2019 | Alimentary Pharmacology & Therapeutics | 9.524 | Q1 | 79 |
| 10 | CDI-associated diarrhea | 10.5694/mja17.00295 | Moayyedi | 2017 | Medical Journal of Australia | 12.776 | Q1 | 78 |
| 11 | Recurrent CDI | 10.1093/Cid/ciy721 | Tariq | 2019 | Clinical Infectious Diseases | 20.999 | Q1 | 74 |
| 12 | Irritable bowel syndrome | 10.14309/ajg.0000000000000198 | Xu | 2019 | The American Journal of Gastroenterology | 12.045 | Q1 | 72 |
| 13 | Inflammatory bowel disease | 10.1080/19490976.2017.1353848 | Qazi | 2017 | Gut Microbes | 9.434 | Q1 | 72 |
| 14 | Recurrent CDI | 10.1371/journal.pone.0210016 | Hui | 2019 | PLoS One | 3.752 | Q2 | 58 |
| 15 | Total outcomes in FMT | 10.1111/apt.15116 | Lai | 2019 | Alimentary Pharmacology & Therapeutics | 9.524 | Q1 | 57 |
| 16 | Chronic refractory pouchitis | 10.1111/apt.13905 | Segal | 2017 | Alimentary Pharmacology & Therapeutics | 9.524 | Q1 | 56 |
| 17 | Ulcerative colitis | 10.1371/journal.pone.0157259 | Shi | 2016 | PLoS One | 3.752 | Q2 | 46 |
| 18 | Inflammatory bowel disease | 10.1155/2018/8941340 | Fang | 2018 | BioMed Research International | 3.246 | Q3 | 44 |
| 19 | Recurrent CDI | 10.1016/j.eclinm.2020.100642 | Baunwall | 2020 | eClinicalMedicine | 17.033 | Q1 | 34 |
| 20 | CDI in IBD patients | 10.1093/ecco-jcc/jjy031 | Chen | 2018 | Journal of Crohn's and Colitis | 10.020 | Q1 | 30 |